Dr. Bob Walker will provide updates on this program shortly ... And with this progress, we are already seeing that ...

The US Food and Drug Administration (FDA) has removed the clinical hold on the Investigational New Drug (IND) application for ...

China has reported seven more H9N2 avian flu infections in humans, mostly involving children and all in people whose symptoms ...

Novavax yesterday announced that the US Food and Drug Administration (FDA ... said today in its weekly avian flu update.

The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...

The SLOOS report will provide updates on the conditions ... Shift4 Payments Inc (FOUR), Mosaic (MOS), Roivant Sciences (ROIV), Repligen (RGEN), Rocket Lab USA (RKLB), Legend Bio (LEGN), Marathon ...

FORT MILL, SC / ACCESSWIRE / November 13, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced ...

BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...

J.P. Morgan analyst Eric Joseph maintained a Sell rating on Novavax (NVAX – Research Report) yesterday and set a price target of $9.00. Eric Joseph has given his Sell rating due to a combination of ...

Shares of Novavax Inc. NVAX slid 6.10% to $8.46 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.09% to 19,281.40 ...

Novavax stock fell sharply after the pharmaceutical company cut its forecast for annual revenue despite better-than-expected ...